Predicting drug sensitivity and resistance: Profiling ABC transporter genes in cancer cells

Cancer Cell

Volumn 6, Issue 2, 2004, Pages 129-137

  Szakács, Gergely ^a   Annereau, Jean Philippe ^a   Lababidi, Samir ^a   Shankavaram, Uma ^a   Arciello, Angela ^a   Bussey, Kimberly J ^a   Reinhold, William ^a   Guo, Yanping ^b   Kruh, Gary D ^b   Reimers, Mark ^a   Weinstein, John N ^a   Gottesman, Michael M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; COLCHICINE; DIMETHYL SULFOXIDE; MESSENGER RNA; VALSPODAR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RESPONSE; DRUG SENSITIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; DNA MICROARRAY; DRUG RESISTANCE; DRUG SCREENING; GENETICS; METABOLISM; NEOPLASM; STATISTICS; TUMOR CELL LINE;

ANIMALIA;

ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; STATISTICS;

EID: 5144226566     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.06.026     Document Type: Article

References (45)

1. Aleman C., Annereau J.P., Liang X.J., Cardarelli C.O., Taylor B., Yin J.J., Aszalos A., Gottesman M.M. P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential. Cancer Res. 63:2003;3084-3091
2. Alvarez M., Paull K., Monks A., Hose C., Lee J.S., Weinstein J., Grever M., Bates S., Fojo T. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J. Clin. Invest. 95:1995;2205-2214
3. Bates S.E., Zhan Z., Dickstein B., Lee J.S., Scala S., Fojo A.T., Paull K., Wilson W. Reversal of multidrug resistance. Prog. Clin. Biol. Res. 389:1994;33-37
4. Bergman A.M., Pinedo H.M., Talianidis I., Veerman G., Loves W.J., van der Wilt C.L., Peters G.J. Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines. Br. J. Cancer. 88:2003;1963-1970
5. Blower P.E., Yang C., Fligner M.A., Verducci J.S., Yu L., Richman S., Weinstein J.N. Pharmacogenomic analysis. Correlating molecular substructure classes with microarray gene expression data Pharmacogenomics J. 2:2002;259-271
6. Borst P., Evers R., Kool M., Wijnholds J. A family of drug transporters. The multidrug resistance-associated proteins J. Natl. Cancer Inst. 92:2000;1295-1302
7. Chernick M.R. Bootstrap Methods. A Practitioner's Guide:1999;John Wiley & Sons, Inc, New York
8. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654
9. Deeley R.G., Cole S.P. Function, evolution and structure of multidrug resistance protein (MRP). Semin. Cancer Biol. 8:1997;193-204
10. Ellison G., Klinowska T., Westwood R.F., Docter E., French T., Fox J.C. Further evidence to support the melanocytic origin of MDA-MB-435. Mol. Pathol. 55:2002;294-299
11. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer. Role of ATP-dependent transporters Nat. Rev. Cancer. 2:2002;48-58
12. Guo Y., Kotova E., Chen Z.S., Lee K., Hopper-Borge E., Belinsky M.G., Kruh G.D. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′- dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl) adenine. J. Biol. Chem. 278:2003;29509-29514
13. Gupta R.S., Murray W., Gupta R. Cross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line. Br. J. Cancer. 58:1988;441-447
14. Homolya L., Hollo M., Muller M., Mechetner E.B., Sarkadi B. A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells. Br. J. Cancer. 73:1996;849-855
15. Honjo Y., Morisaki K., Huff L.M., Robey R.W., Hung J., Dean M., Bates S.E. Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1). Cancer Biol. Ther. 1:2002;696-702
16. Horton J.K., Houghton P.J., Houghton J.A. Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenografts. Biochem. Pharmacol. 37:1988;3995-4000
17. Imai Y., Nakane M., Kage K., Tsukahara S., Ishikawa E., Tsuruo T., Miki Y., Sugimoto Y. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol. Cancer Ther. 1:2002;611-616
18. Izquierdo M.A., Shoemaker R.H., Flens M.J., Scheffer G.L., Wu L., Prather T.R., Scheper R.J. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int. J. Cancer. 65:1996;230-237
19. Kabanov A.V., Batrakova E.V., Alakhov V.Y. An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. J. Control. Release. 91:2003;75-83
20. Kellen J.A. The reversal of multidrug resistance. An update J. Exp. Ther. Oncol. 3:2003;5-13
21. Kruh G.D., Belinsky M.G. The MRP family of drug efflux pumps. Oncogene. 22:2003;7537-7552
22. Langmann T., Mauerer R., Zahn A., Moehle C., Probst M., Stremmel W., Schmitz G. Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin. Chem. 49:2003;230-238
23. Lee J.S., Paull K., Alvarez M., Hose C., Monks A., Grever M., Fojo A.T., Bates S.E. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol. Pharmacol. 46:1994;627-638
24. Litman T., Druley T.E., Stein W.D., Bates S.E. From MDR to MXR. New understanding of multidrug resistance systems, their properties and clinical significance Cell. Mol. Life Sci. 58:2001;931-959
25. Mosser J., Douar A.M., Sarde C.O., Kioschis P., Feil R., Moser H., Poustka A.M., Mandel J.L., Aubourg P. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 361:1993;726-730
26. Pajeva I.K., Wiese M. Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance. Explanation of structural variety (hypothesis) J. Med. Chem. 45:2002;5671-5686
27. Paull K.D., Shoemaker R.H., Hodes L., Monks A., Scudiero D.A., Rubinstein L., Plowman J., Boyd M.R. Display and analysis of patterns of differential activity of drugs against human tumor cell lines. Development of mean graph and COMPARE algorithm J. Natl. Cancer Inst. 81:1989;1088-1092
28. Prades C., Arnould I., Annilo T., Shulenin S., Chen Z.Q., Orosco L., Triunfol M., Devaud C., Maintoux-Larois C., Lafargue C., et al. The human ATP binding cassette gene ABCA13, located on chromosome 7p12.3, encodes a 5058 amino acid protein with an extracellular domain encoded in part by a 4.8-kb conserved exon. Cytogenet. Genome Res. 98:2002;160-168
29. Rabow A.A., Shoemaker R.H., Sausville E.A., Covell D.G. Mining the National Cancer Institute's tumor-screening database. Identification of compounds with similar cellular activities J. Med. Chem. 45:2002;818-840
30. Reiner A., Yekutieli D., Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics. 19:2003;368-375
31. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P., Iyer V., Jeffrey S.S., Van de Rijn M., Waltham M., et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24:2000;227-235
32. Sarkadi B., Muller M., Hollo Z. The multidrug transporters-proteins of an ancient immune system. Immunol. Lett. 54:1996;215-219
33. Scala S., Akhmed N., Rao U.S., Paull K., Lan L.B., Dickstein B., Lee J.S., Elgemeie G.H., Stein W.D., Bates S.E. P-glycoprotein substrates and antagonists cluster into two distinct groups. Mol. Pharmacol. 51:1997;1024-1033
34. Scherf U., Ross D.T., Waltham M., Smith L.H., Lee J.K., Tanabe L., Kohn K.W., Reinhold W.C., Myers T.G., Andrews D.T., et al. A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24:2000;236-244
35. Shen D.W., Cardarelli C., Hwang J., Cornwell M., Richert N., Ishii S., Pastan I., Gottesman M.M. Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J. Biol. Chem. 261:1986;7762-7770
36. Shoemaker R.H. Genetic and epigenetic factors in anticancer drug resistance. J. Natl. Cancer Inst. 92:2000;4-5
37. Sikic B.I. Modulation of multidrug resistance. A paradigm for translational clinical research Oncology. 13:1999;183-187
38. Staunton J.E., Slonim D.K., Coller H.A., Tamayo P., Angelo M.J., Park J., Scherf U., Lee J.K., Reinhold W.O., Weinstein J.N., et al. Chemosensitivity Prediction by Transcriptional Profiling. Proc. Natl. Acad. Sci. USA. 12:2001;10787-10792
39. Stinson S.F., Alley M.C., Kopp W.C., Fiebig H.H., Mullendore L.A., Pittman A.F., Kenney S., Keller J., Boyd M.R. Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen. Anticancer Res. 12:1992;1035-1053
40. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., and Speleman, F. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034.
41. Weinstein J.N., Kohn K.W., Grever M.R., Viswanadhan V.N., Rubinstein L.V., Monks A.P., Scudiero D.A., Welch L., Koutsoukos A.D., Chiausa A.J., et al. Neural computing in cancer drug development. Predicting mechanism of action Science. 258:1992;447-451
42. Weinstein J.N., Myers T.G., O'Connor P.M., Friend S.H., Fornace A.J. Jr., Kohn K.W., Fojo T., Bates S.E., Rubinstein L.V., Anderson N.L., et al. An information-intensive approach to the molecular pharmacology of cancer. Science. 275:1997;343-349
43. Westfall P.H., Young S.S. Resampling-Based Multiple Testing. Examples and Methods for p-value Adjustment:1993;Wiley, New York
44. Wu L., Smythe A.M., Stinson S.F., Mullendore L.A., Monks A., Scudiero D.A., Paull K.D., Koutsoukos A.D., Rubinstein L.V., Boyd M.R., et al. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res. 52:1992;3029-3034
45. Yabuuchi H., Takayanagi S., Yoshinaga K., Taniguchi N., Aburatani H., Ishikawa T. ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. Biochem. Biophys. Res. Commun. 6:2002;410-417